The Foundation for the National Institutes of Health is releasing four open-competition funding opportunities for the Accelerating Medicines Partnership® in Common Metabolic Diseases. Investigators working with genetic, genomic, and other tissues/omics data, and analytic tools and methods relating to common metabolic diseases including obesity, cardiovascular and kidney diseases, NAFLD/NASH, and diabetes and make them publicly available in the AMP CMD Knowledge Portal are encouraged to apply. Learn more about the program and view the RFPs here. The deadline for applications has now been extended to January 28, 2022.
md, t1d, t2d, cd, cvd, sleep